| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |